Linden Thomas Advisory Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
3,766
-656
-15% -$303K 0.16% 214
2026
Q1
$2.12M Sell
4,422
-296
-6% -$152K 0.2% 170
2025
Q4
$2.65M Sell
4,718
-22
-0.5% -$12.5K 0.27% 103
2025
Q3
$2.44M Sell
4,740
-23
-0.5% -$10K 0.25% 117
2025
Q2
$1.49M Buy
4,763
+17
+0.4% +$5.1K 0.16% 202
2025
Q1
$1.45M Buy
4,746
+87
+2% +$29.3K 0.19% 199
2024
Q4
$1.55M Buy
4,659
+140
+3% +$47.5K 0.2% 187
2024
Q3
$1.51M Buy
4,519
+112
+3% +$42.5K 0.21% 190
2024
Q2
$1.82M Sell
4,407
-1,971
-31% -$781K 0.28% 118
2024
Q1
$2.58M Buy
6,378
+148
+2% +$52K 0.41% 45
2023
Q4
$1.91M Buy
6,230
+299
+5% +$80.7K 0.36% 74
2023
Q3
$1.44M Sell
5,931
-2,282
-28% -$584K 0.32% 118
2023
Q2
$1.97M Buy
8,213
+139
+2% +$28.9K 0.44% 52
2023
Q1
$1.52M Buy
8,074
+180
+2% +$37.2K 0.38% 93
2022
Q4
$1.68M Buy
+7,894
New +$1.58M 0.47% 57

Other funds holding MEDP

Linden Thomas Advisory Services's MEDP Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Medpace (MEDP) stake by 15% in Q2 2026, selling an estimated $303K and leaving 3,766 shares worth $1.99M. The position accounts for 0.16% of the portfolio, ranked #214.

Linden Thomas Advisory Services first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.65M in Q4 2025. 149 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Linden Thomas Advisory Services held 3,766 shares of Medpace worth $1.99M as of Q2 2026.
  • Linden Thomas Advisory Services sold 656 Medpace shares in Q2 2026, an estimated $303K.
  • Medpace made up 0.16% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #214 holding.
  • Linden Thomas Advisory Services first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's Medpace position peaked at $2.65M in Q4 2025.
  • 149 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.